Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Identification of a second G–C-rich promoter conserved in the human, murine and rat tumor suppressor genes HIC1

Abstract

The BTB/POZ transcriptional repressor HIC1 (Hypermethylated in Cancer 1) is a tumor suppressor gene located at chromosome 17p13.3, a region frequently hypermethylated or deleted in human tumors and in a contiguous-gene syndrome, the Miller–Dieker syndrome. The human and murine HIC1 genes are composed of two alternative 5′ exons, 1a and 1b fused to a large second coding exon 2. Exon 1a is a noncoding exon associated with a major G–C-rich promoter whereas exon 1b is a downstream coding exon associated with a minor TATA box promoter. By human–mouse genome comparison, we have identified a short upstream conserved sequence containing G–C boxes which were shown to be functional. Transcripts initiating from this new promoter were detected in various human and mouse tissues and contained a long 5′-UTR sequence, called 1c which encompass the G–C-rich promoter associated with exon 1a and uses the same splice donor site. RT–PCR analyses of two primary breast epithelial cell lines identified two other 5′-UTRs generated by alternative splicing within exon 1c. Our results thus highlight the existence of an unexpected complex transcriptional regulation of HIC1.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Baylin SB, Esteller M Rountree MR, Bachman KE, Schuebel K and Hermann JG . (2001). Hum. Mol. Genet., 10, 687–692.

  • Baylin SB, Herman JG, Graff JR, Vertino PM and Issa JP . (1998). Adv. Cancer Res., 72, 141–196.

  • Bruening W, Prowse AH, Schultz DC, Holgado-Madruga M, Wong A and Godwin AK . (1999). Cancer Res., 59, 4973–4983.

  • Carter MG, Johns MA, Zeng X, Zhou L, Zink MC, Mankowski JL, Donovan DM and Baylin SB . (2000). Hum. Mol. Genet., 9, 413–419.

  • Chen WY, Zeng X, Carter M, Morell CN, Chiu Yen R-W, Esteller M, Watkins DN, Herman JG, Mankowski JL and Baylin SB . (2003). Nat. Genet., 33, 197–202.

  • Deltour S, Guérardel C and Leprince D . (1999). Proc. Natl. Acad. Sci. USA, 96, 14831–14836.

  • Feltus FA, Lee EK, Costello JF, Plass C and Vertino PM . (2003). Proc. Natl. Acad. Sci. USA, 100, 12253–12258.

  • Fujii H, Biel MA, Zhou W, Weitzman SA, Baylin SB and Gabrielson E . (1998). Oncogene, 16, 2159–2164.

  • Guérardel C, Deltour S, Pinte S, Monte D, Bègue A, Godwin AK and Leprince D . (2001). J. Biol. Chem., 276, 3078–3089.

  • Grimm C, Spörle R, Schmid TE, Adler I-D, Adamski A, Schughart K and Graw J . (1999). Hum. Mol. Genet., 8, 697–710.

  • Han B, Dong Z, Liu Y, Chen Q, Hashimoto K and Zhang J-T . (2003). Oncogene, 22, 5325–5337.

  • Kanai Y, Hui A, Sun L, Ushijima S, Sakamoto M, Tsuda M and Hirohashi S . (1999). Hepatology, 29, 703–709.

  • Ko LJ and Prives C . (1996). Genes Dev., 10, 1054–1072.

  • Kozak M . (1991). J. Cell Biol., 115, 887–903.

  • Liscia DS, Morizio R, Venesio T, Palenzona C, Donadio M and Callahan R . (1999). Br. J. Cancer, 80, 821–826.

  • Makos-Wales M, Biel M, El Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ and Baylin SB . (1995). Nat. Med., 1, 570–577.

  • Melki JR, Vincent PC and Clark SJ . (1999). Leukemia, 13, 877–883.

  • Philips NJ, Ziegler MR and Deaven LL . (1996). Cancer Lett., 102, 85–90.

  • Rood BR, Zhang H, Weitman DM and Cogen PH . (2002). Cancer Res., 62, 3794–3797.

  • Schultz D, Vanderveer L, Berman DB, Hamilton TC, Wong AJ and Godwin AK . (1996). Cancer Res., 56, 1997–2002.

  • Yingling J, Toyo-oka K and Wynshaw-Boris A . (2003). Am. J. Hum. Genet., 73, 475–488.

  • Yuasa Y . (2002). Mech. Ageing Dev., 123, 1649–1654.

Download references

Acknowledgements

This work was supported by funds from CNRS, the PASTEUR Institute, Ligue Régionale contre le Cancer (Comité de l'Aisne) and a grant from the NIH (Ovarian Cancer SPORE P50 CA83638). We thank Patrick Dumont for dissection of mouse tissues and Agnès Bègue for the murine ovaries cDNA fractions. We also thank Agnès Bègue, Jean Coll and Brian Rood for their comments on the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dominique Leprince.

Additional information

The nucleotide sequences reported in this paper have been deposited to the EMBL database under Accession Numbers: AJ414163, AJ550616, AJ585343, AJ583693, AJ583594 and AJ585343

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pinte, S., Guérardel, C., Deltour-Balerdi, S. et al. Identification of a second G–C-rich promoter conserved in the human, murine and rat tumor suppressor genes HIC1. Oncogene 23, 4023–4031 (2004). https://doi.org/10.1038/sj.onc.1207504

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207504

Keywords

This article is cited by

Search

Quick links